← Back to Search

Text Messaging Program for Pregnancy Health

N/A
Recruiting
Led By Patti Janssen, PhD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month post birth
Awards & highlights

Study Summary

This trial tests if text messages promoting healthy pregnancy behaviours can improve knowledge, reduce anxiety, and improve outcomes for pregnant people.

Who is the study for?
This trial is for pregnant individuals in Canada (except British Columbia) who are at or before 15 weeks gestation with a single pregnancy. They must be able to read and understand English at an 8th-grade level and be comfortable completing online surveys.Check my eligibility
What is being tested?
The SmartMom clinical trial tests if receiving text messages designed to promote healthy behaviors during pregnancy can improve knowledge, reduce depression/anxiety/fear of childbirth, encourage positive health habits, and better maternal/fetal/newborn outcomes compared to general interest texts.See study design
What are the potential side effects?
Since this study involves educational text messaging, there are no direct medical side effects expected from participating. However, participants may experience increased screen time.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month post birth
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month post birth for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Attendance at prenatal care visits through pregnancy
Change in weight during pregnancy
Secondary outcome measures
Changes in anxiety through pregnancy
Changes in depression through pregnancy
Changes in fear of childbirth through pregnancy
+7 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Intervention: SmartMom messagingActive Control1 Intervention
Participants receive three text messages per week with evidence-based information to promote healthy behaviours during pregnancy.
Group II: Control messagingPlacebo Group1 Intervention
Participants receive one text message per week with general information about pregnancy but not about making healthy choices.

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,418 Previous Clinical Trials
2,464,040 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,345 Previous Clinical Trials
26,450,436 Total Patients Enrolled
Patti Janssen, PhDPrincipal InvestigatorUniversity of British Columbia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do you have any vacancies for individuals wishing to participate in this trial?

"Affirmative. Clinicaltrials.gov indicates that recruitment is ongoing for this trial, which was posted on November 10th 2023 and last updated on the twentieth of the same month. Currently, 3078 patients are needed from 1 site."

Answered by AI

What is the ultimate purpose of this clinical exploration?

"This clinical trial, which will span 38 weeks of gestation to assess efficacy, is attempting to track prenatal care attendance. Secondary objectives include the measurement of adverse pregnancy outcomes such as gestational diabetes and stillbirths via patient-reported data or provincial registries linked with personal health numbers. Additionally, changes in anxiety levels among participants are recorded using a 33-item Pregnancy Specific Anxiety Tool (PSAT) while rates of planned vaginal birth after cesarean section will also be monitored."

Answered by AI

What is the highest number of participants engaged in this experiment?

"Affirmative. Per the clinicaltrials.gov database, this medical trial is currently seeking suitable patients and was last updated on November 20th 2023 after its initial postdate of November 10th that same year. A total of 3078 participants are needed for this study at a single registered site."

Answered by AI
~2052 spots leftby Feb 2026